Oxford-AstraZeneca vaccine: common adverse events in Spain

As of December 12, 2021, a total of 6,409 cases of pyrexia (fever) had been reported in Spain after receiving the vaccine against COVID-19 developed by Oxford and AstraZeneca. Similarly to the adverse events recorded with the Pfizer/BioNTech vaccine, pyrexia was on top of the list, followed by headache and myalgia, which reached around 4.7 thousand and 2.9 thousand cases. As of that date, more than 9.7 million Vaxzevria (AstraZeneca) vaccines had been used in the European country.

Most common adverse events reported after receiving the AstraZeneca (Vaxzevria) vaccine against COVID-19 in Spain as of December 12, 2021

Characteristic	Number of cases
Pyrexia	6,409
Headache	4,740
Myalgia	2,982
Chills	1,759
Discomfort	1,633
Pain in the vaccination area	1,308
Fatigue	1,264
Dizziness	1,089
Sickness	1,087
Arthralgia	822

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2021

More information

Region

Spain

Survey time period

as of December 12, 2021

Supplementary notes

Includes any kind of adverse event notified after receiving the coronavirus (COVID-19) vaccine. Adverse events are not to be interpreted as induced by the vaccine until a casual relationship is confirmed.

As of December 12, 2021 a total of 9,791,385 doses of the Oxford-AstraZeneca vaccine had been administered in Spain.

Citation formats